how many people take glp 1 GLP-1 trends 2025: real-world data, patient outcomes & future therapies 1 in 8 U.S. Adults

In those with cholelithiasis, the relative risk of symptomatic cholelithiasis was 1.6, 0.9, and 1.4 in liraglutide, dulaglutide, and semaglutide versus control with number needed to harm of 3.14, 16.67, and 5.56, respectively

Support for the thyroid and gonads Research and observations indicate that this peptide can have a positive effect on the hypothalamic-pituitary-adrenal axis

Knezevic et al., 2021b) and central vessels (Gojkovic et al., 2021a) or after the intragastric application of absolute alcohol (Gojkovic et al., 2021b) and intraperitoneal application of the lithium overdose (Strbe et al., 2021)

Improved blood sugar control (slower glucose spikes)